How Stifel Nicolaus Currently Rates Halyard Health Inc (NYSE:HYH)
In a comprehensive report revealed today, Stifel Nicolaus analysts began issuing Halyard Health Inc (NYSE:HYH) coverage with “Buy” rating.
From a total of 3 analysts covering Halyard Health Inc (NYSE:HYH) stock, 2 rate it a ”Buy”, 1 a “Sell”, and 1 a ”Hold”. This means that 50% of the ratings are positive. The highest target price is $40 while the lowest target price is $27. The mean of all analyst targets is $35.67 with a 8.42% above today’s ($32.9) stock price. Halyard Health Inc was the topic of 5 analyst reports since July 21, 2015 according to the firm StockzIntelligence Inc. Morgan Stanley downgraded shares on October 12 to “Underweight” rating. Raymond James initiated HYH stock in a recent report from July 21 with “Market Perform” rating.
The stock decreased 0.03% or $0.01 on December 2, striking $32.9. Approximately 150 shares of stock traded hands. Halyard Health Inc (NYSE:HYH) has declined 30.88% since April 29, 2015 and is downtrending. It has underperformed by 30.68% the S&P500.
Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The company has a market cap of $1.53 billion. The Firm has two business divisions: Surgical and Infection Prevention and Medical Devices. It currently has negative earnings. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
According to Zacks Investment Research, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia.” Get a free copy of the Zacks research report on Halyard Health Inc (HYH).